首次完整IVF周期中囊胚与卵裂期胚胎移植的累积活产率比较
STUDY QUESTION: Is there a difference in the odds of a live birth following blastocyst- versus cleavage-stage embryo transfer in the first complete cycle of IVF? SUMMARY ANSWER: After adjusting for indication bias, there was not enough evidence to suggest a difference in the odds…
要点
- 未调整时囊胚移植累积活产率56.5%,高于卵裂期34.8%。
- 结论需考虑回顾性数据及未调整吸烟、BMI、胚胎质量等混杂因素。
核心结论
- 调整指征偏倚后,囊胚与卵裂期胚胎移植在首次完整IVF周期中的活产odds无足够证据显示差异。
- 未调整的累积活产率在囊胚组更高,但该差异可由夫妇特征不平衡解释。
研究设计与样本
- 夫妇于1999年1月1日至2010年7月30日在英国持牌诊所开始首次IVF/ICSI治疗。
- 数据来源于HFEA注册库,分析自体配子IVF/ICSI治疗。
- 采用二元logistic回归估计调整后活产odds,并用逆概率治疗加权处理组间特征不平衡。
主要发现
- 94 294对(93.7%)夫妇接受卵裂期胚胎移植,6316对(6.3%)接受囊胚移植。
- 首次完整IVF/ICSI周期(含首次取卵相关全部新鲜与冻融胚胎移植)累积活产率:囊胚组56.5%,卵裂期组34.8%。
临床怎么用
- 在咨询中应告知患者:调整指征偏倚后,囊胚与卵裂期移植的累积活产机会无足够证据显示差异。
- 未调整的累积活产率差异不应直接归因于移植阶段,需考虑夫妇特征不平衡。
- 原文作者认为,在条件允许时向更广泛夫妇提供囊胚移植可能提高累积成功率,但该表述基于未调整比较。
局限性
- HFEA数据集为回顾性,链接数据仅至2010年。
- 无法调整吸烟状态、BMI和胚胎质量等混杂因素,因HFEA未在全国层面收集这些数据。
- 可能存在未知的夫妇、治疗或诊所变量影响结果。
- 无法评估未进行胚胎移植女性的预期移植阶段,故将其排除。
- 未分析围产结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is there a difference in the odds of a live birth following blastocyst- versus cleavage-stage embryo transfer in the first complete cycle of IVF? SUMMARY ANSWER: After adjusting for indication bias, there was not enough evidence to suggest a difference in the odds of live birth following blastocyst- versus cleavage-stage embryo transfer in the first complete cycle of IVF. WHAT IS KNOWN ALREADY: Replacement of blastocyst-stage embryos has become the dominant practice in IVF but there is uncertainty about whether this technique offers an improved chance of cumulative live birth over all fresh and frozen-thawed embryo transfer attempts associated with a single oocyte retrieval. STUDY DESIGN, SIZE, DURATION: National population-based retrospective cohort study of 100 610 couples who began their first IVF/ICSI treatment at a licenced UK clinic between 1 January 1999 and 30 July 2010. PARTICIPANTS/MATERIALS, SETTING, METHODS: Data from the Human Fertilisation and Embryology Authority (HFEA) register on IVF/ICSI treatments using autologous gametes between 1999 and 2010 were analysed. The primary outcome was the live birth rate over the first complete cycle of IVF. Cumulative live birth rates (CLBR) were compared for couples who underwent blastocyst and cleavage transfer, and the adjusted odds of live birth over the first complete cycle were estimated for each group using binary logistic regression. This analysis was repeated within groups of female age, oocytes collected and primary versus secondary infertility. Inverse probability of treatment weighting was used to account for the imbalance in couple characteristics between treatment groups. MAIN RESULTS AND THE ROLE OF CHANCE: In total, 94 294 (93.7%) couples had a cleavage-stage embryo transfer while 6316 (6.3%) received blastocysts. Over the first complete cycle of IVF/ICSI (incorporating all fresh and frozen-thawed embryo transfers associated with the first oocyte retrieval), the CLBR was increased in those who underwent blastocyst transfer (56.5%) compared to cleavage-stage embryo transfer (34.8%). However, after accounting for the imbalance between exposures, blastocyst transfer did not significantly influence the odds of live birth over the first complete cycle (adjusted odds ratio: 1.03 (0.96, 1.10)). LIMITATIONS, REASONS FOR CAUTION: Limitations of our study include the retrospective nature of the HFEA dataset and availability of linked data up until 2010. We were unable to adjust for some confounders, such as smoking status, BMI and embryo quality, as these data are not collected at national level by the HFEA. Similarly, there may be unknown couple, treatment or clinic variables that may influence our results. We were unable to assess the intended stage of embryo transfer for women who did not have an embryo replaced, and therefore excluded them from our study. Perinatal outcomes were not included in our analyses and would be a useful basis for future study. WIDER IMPLICATIONS OF THE FINDINGS: Our findings show that blastocyst-stage embryo transfer may offer an improved chance of live birth in both the first fresh and the first complete cycle of IVF/ICSI compared to cleavage-stage transfer, even in couples with typically poorer prognoses. Where possible, offering blastocyst transfer to a wider range of couples may increase cumulative success rates. STUDY FUNDING/COMPETING INTEREST(S): N.J.C. received a Wolfson Foundation Intercalated Degree Research Fellowship funded by the Wolfson Foundation, through the Royal College of Physicians. This work was supported by a Chief Scientist Office Postdoctoral Training Fellowship in Health Services Research and Health of the Public Research (Ref PDF/12/06) held by D.J.M. The views expressed here are those of the authors and not necessarily those of the Chief Scientist Office or the Wolfson Foundation. The funders did not have any role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; nor in the decision to submit the paper for publication. None of the authors has any conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.
引用
- Cameron NJ, Bhattacharya S, McLernon DJ, et al. Cumulative live birth rates following blastocyst- versus cleavage-stage embryo transfer in the first complete cycle of IVF: a population-based retrospective cohort study. Hum Reprod. 2020. PMID: 32949234. doi:10.1093/humrep/deaa186
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。